Alternating Rabacfosadine/Doxorubicin: Efficacy and Tolerability in Naïve Canine Multicentric Lymphoma

BACKGROUND: Standard of care treatment for multicentric lymphoma in dogs remains doxorubicin (DOX)‐based combination chemotherapy, but owners may hesitate to commit the time and financial resources to complete such a protocol, typically requiring 12–16 visits. Rabacfosadine (RAB), a double prodrug o...

Descripción completa

Detalles Bibliográficos
Autores principales: Thamm, D.H., Vail, D.M., Post, G.S., Fan, T.M., Phillips, B.S., Axiak‐Bechtel, S., Elmslie, R.S., Klein, M.K., Ruslander, D.A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
SMALL ANIMAL
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5435064/
https://www.ncbi.nlm.nih.gov/pubmed/28370378
http://dx.doi.org/10.1111/jvim.14700

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5435064/
https://www.ncbi.nlm.nih.gov/pubmed/28370378
http://dx.doi.org/10.1111/jvim.14700

Ejemplares similares